ImmunoCellular Therapeutics (IMUC) Reports Q4 Loss of $1.23/Share
Tweet
Share
E-mailImmunoCellular Therapeutics (NYSE: IMUC) reported Q4 EPS of ($1.23), versus ($7.89) reported last year.
For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
